eman_mohamed2

Eman E Abu-Dief

Professor - professor of Histology,Faculty of Medicine,Sohag University

Faculty of medicine

Address: Histology Department- Faculty of medicine- Sohag University

5

Like

Publications Which contain the keyword: cirrhosis


2023-05-25 12:16:50 Keywords cirrhosis, spontaneous bacteri,
Serum copeptin is associated with major complications of liver cirrhosis and spontaneous bacterial peritonitis
Abstract Aim of the study: We aimed to investigate the possible association between serum copeptin and complications of liver cirrhosis, including its potential role as a stress biomarker in spontaneous bacterial peritonitis (SBP). Material and methods: This cross-sectional study included 89 cirrhotic ascitic patients (37 with SBP and 52 without SBP) admitted to Sohag University Hospitals, Egypt, between June 2021 ... Read more

Von Willibrand Factor Antigen as a Non Invasive Predictor of Portal Hypertension in Patients with Liver Cirrhosis
In cirrhotic livers, increased resistance to portal blood flow is the primary factor in the pathophysiology of portal hypertension (PH) and is caused by structural abnormalities in the hepatic vascular architecture and an increased hepatic vascular tone. Von Willebrand factor antigen (vWF Ag) is released by activated endothelial cells (ECs) and therefore represents an indicator of EC activation and plays ... Read more

2018-11-17 18:49:24 Keywords Portal Hypertension, doppler US, cirrhosis, Oesophageal Varices,
Role of portal haemodynamic parameters in prediction of oesophageal varices in cirrhotic patients
BACKGROUND AND STUDY AIMS Screening all cirrhotic patients by endoscopy for detection of varices is not cost-effective as the number of patients increases by time and half of them still would not have developed varices 10 years after being diagnosed with cirrhosis. Therefore, this study aimed to evaluate hepatic haemodynamic Doppler parameters in predicting the presence of oesophageal varices (OVs) ... Read more

2018-10-29 14:34:13 Keywords cirrhosis, non-variceal upper,
Outcomes and predictors of in-hospital mortality among cirrhotic patients with non-variceal upper gastrointestinal bleeding in upper Egypt
Background/Aims: Variceal bleeding is one of the most frequent causes of morbidity and mortality among cirrhotic patients. Clinical endoscopic features and outcomes of cirrhotic patients with non-variceal upper gastrointestinal bleeding (NVUGIB) have been rarely reported. Our aim is to identify treatment outcomes and predictors of in-hospital mortality among cirrhotic patients with non-variceal bleeding in Upper Egypt. Materials and Methods: A ... Read more

2018-10-29 15:42:45 Keywords cirrhosis, Ascites, Serum Asci,
Diagnostic Value of Serum Ascites Lipid Gradients in Patients with Ascites
INTRODUCTION: Differential diagnosis of ascites is a common clinical problem. Aim of the work: To study the value of Serum Ascites Lipid Gradients (SALG) of total cholesterol, triglyceride, HDL cholesterol, and LDL cholesterol in the diagnosis of ascites. MATERIALS AND METHODS: The study was conducted on patients with ascites admitted to Tropical Medicine and Gastroenterology Department, Assiut University. The study ... Read more

2018-10-31 01:55:34 Keywords cirrhosis, Prognosis,
Prognosis and determinants of pregnancy outcome in patients with post-hepatitis liver cirrhosis
OBJECTIVES: To evaluate the maternal, fetal, and neonatal outcomes, and address the factors which influence the maternal outcome in pregnant patients with liver cirrhosis. METHODS: A prospective cohort study which included 129 pregnant patients with liver cirrhosis (study group). A total of two control groups were enrolled; the 1st (pregnant non-cirrhotic; n = 647); the 2nd (non-pregnant cirrhotic; n = ... Read more

2018-09-27 23:29:28 Keywords Apoptosis, α-SMA, fibrosis, , Apoptosis, α-SMA, cirrhosis,
Impact of omega-3 fatty acids on evolution of carbon tetrachloride- (CCl4) induced liver cirrhosis in mice : A histological and immunohistochemical study.
Introduction: Cirrhosis is the end stage of any chronic liver disease. It is characterized by diffuse fibrosis with disturbed hepatic architecture. Omega-3 polyunsaturated fatty acids are common antioxidant, anti-inflammatory and anti-fibrotic agents Aim: This study was conducted to investigate the potential effects of omega-3 fatty acids on experimentally induced cirrhosis. Materials and Methods: 60 animals were divided into three groups: ... Read more

2018-09-21 08:26:53 Keywords Lipid profile, cirrhosis,
Lipid profile among cirrhotic patients with and without hepatocellular carcinoma in Upper Egypt
Background/aim:An impaired lipid metabolism is often observed in patients with chronic liver diseases. This study was carried out to determine the lipid profile in cirrhotic patients with and without hepatocellular carcinoma (HCC) and to determine whether it relates to the severity of cirrhosis in Upper Egypt. Patients and methods In an analytical cross-sectional study, 74 patients with cirrhosis and 36 ... Read more

2018-09-21 08:43:18 Keywords cirrhosis, SALG,
Diagnostic Value of Serum Ascites Lipid Gradients in Patients with Ascites
INTRODUCTION: Differential diagnosis of ascites is a common clinical problem. AIM OF THE WORK: To study the value of Serum Ascites Lipid Gradients (SALG) of total cholesterol, triglyceride, HDL cholesterol, and LDL cholesterol in the diagnosis of ascites. MATERIALS AND METHODS: The study was conducted on patients with ascites admitted to Tropical Medicine and Gastroenterology Department, Assiut University. The study ... Read more

2018-09-15 12:32:30 Keywords Portal Hypertension, cirrhosis,
Comparative Study: Valsartan versus Propranolol in Portal Hypertensive Cirrhotic Patients
BACKGROUND: Angiotensin II (A-II) is considered a potential mediator of intrahepatic portal hypertension because its plasma level is elevated in cirrhotic patients. Valsartan-A II blocker- is being tested for use as a portal pressure reducing drug. AIM: To compare haemodynamic changes of 1 week and 1 month treatment with valsartan versus propranolol in cirrhotic portal hypertensive patients. PATIENTS AND METHODS: ... Read more